We measured TFF2 levels in serum samples from healthy controls, as well as patients with PC and periampullary adenocarcinoma and found that TFF2 was specifically overexpressed in PC patients, but not in periampullary adenocarcinoma patients or healthy controls. The gene discussed is TFF2; the disease is pachyonychia congenita.